Literature DB >> 16076377

Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.

Ken-ichi Miyamoto1, Mikiko Ito, Masashi Kuwahata, Shigeaki Kato, Hiroko Segawa.   

Abstract

The mechanisms by which fibroblast growth factor 23 (FGF23) alters inorganic phosphate (Pi) homeostasis is not entirely clear. In the present study, we examined the effect of FGF23 on intestinal sodium-dependent Pi transport in mice. Injection of FGF23(R179Q) markedly reduced serum Pi and 1,25(OH)2D3 levels in normal mice. Those animals show the reduction of intestinal sodium-dependent Pi transport activity and the amount of type IIb sodium-dependent Pi cotransporter (type IIb NaPi) protein in the brush border membrane vesicles. In vitamin D receptor null mice (VDR-/-), FGF23(R179Q) had no effect on intestinal sodium-dependent Pi transport activity and type IIb NaPi protein levels. The present study suggests that FGF23(R179Q) reduces intestinal sodium-dependent Pi transport activity and type IIb NaPi protein levels by a mechanism that is dependent on VDR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076377     DOI: 10.1111/j.1744-9987.2005.00292.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  37 in total

Review 1.  Bone Disease in CKD in Children.

Authors:  Fernando Santos; Lucas Díaz-Anadón; Flor A Ordóñez; Dieter Haffner
Journal:  Calcif Tissue Int       Date:  2021-01-16       Impact factor: 4.333

Review 2.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

3.  The human response to acute enteral and parenteral phosphate loads.

Authors:  Roberto Scanni; Matthias vonRotz; Sigrid Jehle; Henry N Hulter; Reto Krapf
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

Review 4.  Control of phosphate balance by the kidney and intestine.

Authors:  Ichiro Kaneko; Sawako Tatsumi; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2016-11-30       Impact factor: 2.801

Review 5.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

Review 6.  FGF23: its role in renal bone disease.

Authors:  Masafumi Fukagawa; Junichiro James Kazama
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

Review 7.  Can features of phosphate toxicity appear in normophosphatemia?

Authors:  Satoko Osuka; Mohammed S Razzaque
Journal:  J Bone Miner Metab       Date:  2012-01-05       Impact factor: 2.626

Review 8.  Effects of Excessive Dietary Phosphorus Intake on Bone Health.

Authors:  Colby J Vorland; Elizabeth R Stremke; Ranjani N Moorthi; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

9.  Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis.

Authors:  Robert D Thurston; Claire B Larmonier; Pawel M Majewski; Rajalakshmy Ramalingam; Monica Midura-Kiela; Daniel Laubitz; Alain Vandewalle; David G Besselsen; Marcus Mühlbauer; Christian Jobin; Pawel R Kiela; Fayez K Ghishan
Journal:  Gastroenterology       Date:  2009-12-11       Impact factor: 22.682

Review 10.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.